Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 34.30
-0.30 (-0.87%)
At close: May 26, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 5.01 billion as of May 26, 2026. Its market cap has decreased by -3.43% in one year.
Market Cap
5.01B
Enterprise Value
7.20B
Revenue
8.54B
Ranking
n/a
PE Ratio
11.39
Stock Price
34.30
Market Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 5.01B, a decrease of -19.22%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 5.01B | 2.65% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 301.02B |
| Caliway Biopharmaceuticals | 168.09B |
| Lotus Pharmaceutical | 52.82B |
| Heron Neutron Medical | 51.74B |
| Panion & Bf Biotech | 5.30B |
| UnicoCell Biomed | 5.08B |
| Medigen Biotechnology | 5.00B |
| ACRO Biomedical | 5.00B |